Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L VanderBeek

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
JAMA Ophthalmology|November 24, 2017
Revision Surgery After Dacryocystorhinostomy in a National CohortKian Eftekhari, Elliot D Kozin, Brian L VanderBeek
European Journal of Ophthalmology|February 16, 2019
Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edemaRobert M Carroll, Yinxi Yu, Brian L VanderBeek
JAMA Ophthalmology|September 20, 2019
Association of Opioids With Incisional Ocular SurgeryAnton M Kolomeyer, Yinxi Yu, Brian L VanderBeek
JAMA Ophthalmology|December 1, 2022
Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic RetinopathyJonathan C Tsui, Yinxi Yu, Brian L VanderBeek
Ophthalmology|August 19, 2015
The Association between Intravitreal Steroids and Post-Injection Endophthalmitis RatesBrian L VanderBeek, Sarah G Bonaffini, Liyuan Ma
JAMA Ophthalmology|February 7, 2020
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment TrialMeera S Ramakrishnan, Yinxi Yu, Brian L VanderBeek
Retina (Philadelphia, Pa.)|October 13, 2018
COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMABJ Clay Bavinger, Yinxi Yu, Brian L VanderBeek
Retina (Philadelphia, Pa.)|July 29, 2016
SYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONAnastasia Traband, James A Shaffer, Brian L VanderBeek
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 30, 2020
Visit adherence and visual acuity outcomes in patients with diabetic macular edema: a secondary analysis of DRCRnet Protocol TMeera S Ramakrishnan, Yinxi Yu, Brian L VanderBeek
Ophthalmology|August 22, 2017
Re: Yeung et al.: β-blockers and neovascular age-related macular degeneration (Ophthalmology. 2017;124:409-411)Anton M Kolomeyer, Anastasia Traband, Brian L VanderBeek
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
JAMA Ophthalmology|November 24, 2017
Revision Surgery After Dacryocystorhinostomy in a National CohortKian Eftekhari, Elliot D Kozin, Brian L VanderBeek
European Journal of Ophthalmology|February 16, 2019
Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edemaRobert M Carroll, Yinxi Yu, Brian L VanderBeek
JAMA Ophthalmology|September 20, 2019
Association of Opioids With Incisional Ocular SurgeryAnton M Kolomeyer, Yinxi Yu, Brian L VanderBeek
JAMA Ophthalmology|December 1, 2022
Association of Treatment Type and Loss to Follow-up With Tractional Retinal Detachment in Proliferative Diabetic RetinopathyJonathan C Tsui, Yinxi Yu, Brian L VanderBeek
Ophthalmology|August 19, 2015
The Association between Intravitreal Steroids and Post-Injection Endophthalmitis RatesBrian L VanderBeek, Sarah G Bonaffini, Liyuan Ma
JAMA Ophthalmology|February 7, 2020
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment TrialMeera S Ramakrishnan, Yinxi Yu, Brian L VanderBeek
Retina (Philadelphia, Pa.)|October 13, 2018
COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMABJ Clay Bavinger, Yinxi Yu, Brian L VanderBeek
Retina (Philadelphia, Pa.)|July 29, 2016
SYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONAnastasia Traband, James A Shaffer, Brian L VanderBeek
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 30, 2020
Visit adherence and visual acuity outcomes in patients with diabetic macular edema: a secondary analysis of DRCRnet Protocol TMeera S Ramakrishnan, Yinxi Yu, Brian L VanderBeek
Ophthalmology|August 22, 2017
Re: Yeung et al.: β-blockers and neovascular age-related macular degeneration (Ophthalmology. 2017;124:409-411)Anton M Kolomeyer, Anastasia Traband, Brian L VanderBeek
Pageof 12